Holzer & Holzer is investigating whether Tokai Pharmaceuticals, Inc. (“Tokai” or the “Company”) (NASDAQ: TKAI) issued false and misleading statements to investors in connection with its September 18, 2014 initial public offering (the “IPO”).

If you purchased Tokai common stock before March 17, 2015 and suffered a loss on that investment, you are encouraged to contact Corey D. Holzer, Esq. at cholzer@holzerlaw.com or via toll-free telephone at (888) 508-6832, to discuss your legal rights.

Holzer & Holzer, LLC is an Atlanta, Georgia law firm that dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. More information about the firm is available through its website, www.holzerlaw.com and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey D. Holzer is the attorney responsible for its content.

Holzer & Holzer, LLCCorey D. Holzer, Esq., 888-508-6832 (toll-free)cholzer@holzerlaw.com

Novus Therapeutics (NASDAQ:NVUS)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Novus Therapeutics Charts.
Novus Therapeutics (NASDAQ:NVUS)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Novus Therapeutics Charts.